financetom
Business
financetom
/
Business
/
HUL Q4 preview: Low base, demand recovery & GSK Consumer to aid Q4 earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HUL Q4 preview: Low base, demand recovery & GSK Consumer to aid Q4 earnings
Apr 28, 2021 6:49 AM

FMCG major Hindustan Unilever (HUL) will report its Q4 earnings on Thursday. The street is expecting a very strong quarter because of multiple factors. Low base, demand recovery, and GSK Consumer are expected to boost the performance of the FMCG company.

CNBC-TV18 poll expects a near 30 percent growth in revenues. Rs 12,000 crore is what the poll throws up.

EBITDA is likely to grow at nearly 40 percent and net profit to grow nearly 30 percent, close to the Rs 2,000 crore mark.

For HUL, the 30 percent revenue growth will be led by 14-15 percent underlying volume growth, 4-5 percent growth will come in from realisations, and the other 10 percent to come from GSK Consumer.

CNBC-TV18’s Mangalam Maloo has more details. Watch this video for more.

(Edited by : Bivekananda Biswas)

First Published:Apr 28, 2021 3:49 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tommy Hilfiger parent PVH posts rise in Q2 revenue; raises annual outlook
Tommy Hilfiger parent PVH posts rise in Q2 revenue; raises annual outlook
Aug 26, 2025
Overview * PVH Q2 revenue rises 4% to $2.167 bln, exceeding company's guidance * Non-GAAP EPS of $2.52 beats company guidance of $1.85 to $2.00 * Co reaffirms full-year non-GAAP earnings outlook Outlook * PVH raises full-year revenue outlook to increase slightly to low single-digits * PVH reaffirms full-year non-GAAP EPS outlook of $10.75 to $11.00 * Company sees full-year...
Supernus Pharmaceuticals Insider Sold Shares Worth $524,092, According to a Recent SEC Filing
Supernus Pharmaceuticals Insider Sold Shares Worth $524,092, According to a Recent SEC Filing
Aug 26, 2025
04:24 PM EDT, 08/26/2025 (MT Newswires) -- Timothy C Dec, Senior Vice President & CFO, on August 22, 2025, sold 11,780 shares in Supernus Pharmaceuticals ( SUPN ) for $524,092. Following the Form 4 filing with the SEC, Dec has control over a total of 1,246 common shares of the company, with 1,246 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1356576/000119402025000004/xslF345X05/wk-form4_1756239508.xml ...
Telecom firm Ooma meets Q2 revenue estimates, raises FY net income guidance
Telecom firm Ooma meets Q2 revenue estimates, raises FY net income guidance
Aug 26, 2025
Overview * Ooma ( OOMA ) fiscal Q2 rev grows 3% yr/yr, in line with analysts' expectations * Adjusted EPS for fiscal Q2 beats consensus * Adjusted EBITDA for fiscal Q2 exceeds estimates, per LSEG data Outlook * Ooma ( OOMA ) expects Q3 revenue between $67.2 mln and $67.9 mln * Projects Q3 GAAP net income of $0.9 mln...
Littelfuse Insider Sold Shares Worth $3,453,489, According to a Recent SEC Filing
Littelfuse Insider Sold Shares Worth $3,453,489, According to a Recent SEC Filing
Aug 26, 2025
04:24 PM EDT, 08/26/2025 (MT Newswires) -- Alexander Conrad, Senior Vice President & General Manager, Passenger Vehicle, on August 25, 2025, sold 13,210 shares in Littelfuse ( LFUS ) for $3,453,489. Following the Form 4 filing with the SEC, Conrad has control over a total of 3,427 common shares of the company, with 3,427 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/889331/000088933125000164/xslF345X05/form4.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved